vs
AXCELIS TECHNOLOGIES INC（ACLS）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是AXCELIS TECHNOLOGIES INC的1.3倍（$321.1M vs $238.3M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs -18.2%，领先32.6%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs -5.6%），AXCELIS TECHNOLOGIES INC自由现金流更多（$-8.9M vs $-133.8M）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
ACLS vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.3倍
$238.3M
营收增速更快
MDGL
高出216.3%
-5.6%
净利率更高
ACLS
高出32.6%
-18.2%
自由现金流更多
ACLS
多$124.9M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $321.1M |
| 净利润 | $34.3M | $-58.6M |
| 毛利率 | 47.0% | — |
| 营业利润率 | 15.2% | -18.6% |
| 净利率 | 14.4% | -18.2% |
| 营收同比 | -5.6% | 210.8% |
| 净利润同比 | -31.3% | 1.4% |
| 每股收益（稀释后） | $1.11 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSMDGL
| Q4 25 | $238.3M | $321.1M | ||
| Q3 25 | $213.6M | $287.3M | ||
| Q2 25 | $194.5M | $212.8M | ||
| Q1 25 | $192.6M | $137.3M | ||
| Q4 24 | $252.4M | $103.3M | ||
| Q3 24 | $256.6M | $62.2M | ||
| Q2 24 | $256.5M | — | ||
| Q1 24 | $252.4M | $0 |
净利润ACLSMDGL
| Q4 25 | $34.3M | $-58.6M | ||
| Q3 25 | $26.0M | $-114.2M | ||
| Q2 25 | $31.4M | $-42.3M | ||
| Q1 25 | $28.6M | $-73.2M | ||
| Q4 24 | $50.0M | $-59.4M | ||
| Q3 24 | $48.6M | $-107.0M | ||
| Q2 24 | $50.9M | — | ||
| Q1 24 | $51.6M | $-147.5M |
毛利率ACLSMDGL
| Q4 25 | 47.0% | — | ||
| Q3 25 | 41.6% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 46.1% | 96.7% | ||
| Q4 24 | 46.0% | — | ||
| Q3 24 | 42.9% | — | ||
| Q2 24 | 43.8% | — | ||
| Q1 24 | 46.0% | — |
营业利润率ACLSMDGL
| Q4 25 | 15.2% | -18.6% | ||
| Q3 25 | 11.7% | -39.7% | ||
| Q2 25 | 14.9% | -22.2% | ||
| Q1 25 | 15.1% | -57.8% | ||
| Q4 24 | 21.6% | -64.8% | ||
| Q3 24 | 18.3% | -187.1% | ||
| Q2 24 | 20.6% | — | ||
| Q1 24 | 22.4% | — |
净利率ACLSMDGL
| Q4 25 | 14.4% | -18.2% | ||
| Q3 25 | 12.2% | -39.8% | ||
| Q2 25 | 16.1% | -19.9% | ||
| Q1 25 | 14.8% | -53.4% | ||
| Q4 24 | 19.8% | -57.5% | ||
| Q3 24 | 18.9% | -172.0% | ||
| Q2 24 | 19.8% | — | ||
| Q1 24 | 20.4% | — |
每股收益（稀释后）ACLSMDGL
| Q4 25 | $1.11 | $-2.55 | ||
| Q3 25 | $0.83 | $-5.08 | ||
| Q2 25 | $0.98 | $-1.90 | ||
| Q1 25 | $0.88 | $-3.32 | ||
| Q4 24 | $1.54 | $-2.50 | ||
| Q3 24 | $1.49 | $-4.92 | ||
| Q2 24 | $1.55 | — | ||
| Q1 24 | $1.57 | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $198.7M |
| 总债务越低越好 | — | $339.9M |
| 股东权益账面价值 | $1.0B | $602.7M |
| 总资产 | $1.4B | $1.3B |
| 负债/权益比越低杠杆越低 | — | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资ACLSMDGL
| Q4 25 | $374.3M | $198.7M | ||
| Q3 25 | $449.6M | $295.7M | ||
| Q2 25 | $549.8M | $186.2M | ||
| Q1 25 | $587.1M | $183.6M | ||
| Q4 24 | $571.3M | $100.0M | ||
| Q3 24 | $579.4M | $232.7M | ||
| Q2 24 | $548.3M | — | ||
| Q1 24 | $530.2M | $622.5M |
总债务ACLSMDGL
| Q4 25 | — | $339.9M | ||
| Q3 25 | — | $339.8M | ||
| Q2 25 | — | $118.4M | ||
| Q1 25 | — | $118.0M | ||
| Q4 24 | — | $117.6M | ||
| Q3 24 | — | $117.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $116.1M |
股东权益ACLSMDGL
| Q4 25 | $1.0B | $602.7M | ||
| Q3 25 | $1.0B | $625.7M | ||
| Q2 25 | $1.0B | $696.0M | ||
| Q1 25 | $1.0B | $710.6M | ||
| Q4 24 | $1.0B | $754.4M | ||
| Q3 24 | $975.6M | $777.2M | ||
| Q2 24 | $934.9M | — | ||
| Q1 24 | $901.7M | $850.8M |
总资产ACLSMDGL
| Q4 25 | $1.4B | $1.3B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.3B | $1.0B | ||
| Q1 25 | $1.3B | $996.6M | ||
| Q4 24 | $1.3B | $1.0B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | $1.1B |
负债/权益比ACLSMDGL
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $-133.8M |
| 自由现金流率自由现金流/营收 | -3.7% | -41.7% |
| 资本支出强度资本支出/营收 | 1.0% | 0.1% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | $107.0M | — |
8季度趋势，按日历期对齐
经营现金流ACLSMDGL
| Q4 25 | $-6.6M | $-133.5M | ||
| Q3 25 | $45.4M | $79.8M | ||
| Q2 25 | $39.7M | $-47.1M | ||
| Q1 25 | $39.8M | $-88.9M | ||
| Q4 24 | $12.8M | $-104.5M | ||
| Q3 24 | $45.7M | $-67.0M | ||
| Q2 24 | $40.1M | — | ||
| Q1 24 | $42.2M | $-149.2M |
自由现金流ACLSMDGL
| Q4 25 | $-8.9M | $-133.8M | ||
| Q3 25 | $43.3M | $79.0M | ||
| Q2 25 | $37.7M | — | ||
| Q1 25 | $34.8M | — | ||
| Q4 24 | $8.1M | $-104.7M | ||
| Q3 24 | $41.8M | $-67.8M | ||
| Q2 24 | $38.1M | — | ||
| Q1 24 | $40.6M | $-149.5M |
自由现金流率ACLSMDGL
| Q4 25 | -3.7% | -41.7% | ||
| Q3 25 | 20.3% | 27.5% | ||
| Q2 25 | 19.4% | — | ||
| Q1 25 | 18.1% | — | ||
| Q4 24 | 3.2% | -101.3% | ||
| Q3 24 | 16.3% | -109.0% | ||
| Q2 24 | 14.8% | — | ||
| Q1 24 | 16.1% | — |
资本支出强度ACLSMDGL
| Q4 25 | 1.0% | 0.1% | ||
| Q3 25 | 0.9% | 0.3% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 2.6% | 0.0% | ||
| Q4 24 | 1.8% | 0.2% | ||
| Q3 24 | 1.5% | 1.3% | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
现金转化率ACLSMDGL
| Q4 25 | -0.19× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
